Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1998

Hydrolytic activity of candida albicans and their susceptibility to antimycotics

Elżbieta Krajewska-Kułak, Wiaczesław Niczyporuk

Med Sci Monit 1998; 4(4): BR616-620 :: ID: 502120

Abstract

We used 320 strains of Candida albicans, isolated from healthy women (n=95) and from those with vulvovaginitis candidiasis(n=225). The aim of this study was to assess the hydrolytic activity of the tested strains and their resistance to antimycotics from healthy women and from women with vulvovaginitis. Generally 30.03% strains of Candida albicans were resistant to all tested antimycotics. 39.46% of isolates from women with vulvovaginitis candidamycetica were resistant to the tested antimycotics in comparison to 7.72% of healthy women. Isolates from women with vulvovaginitis candidamycetica were resistant to fluconazole (72%), pimaricine (65.33%) and ketoconazole (58.67%). Among isolates from healthy women, no resistant strains to 5-fluorocytosine were found. 82.22% of isolates from women with vulvovaginitis were resistant to two or more drugs, incomparison to and only 14.74% of isolates from healthy women. Isolates from women with vulvovaginitis incomparison with healthy, women had a significanty higher hydrolytic activity. Isolates from women with vaginitis, had the highest activity of leucine arylamidase, lipase esterase and esterase. Isolates from healthy women had the highest activity of leucine arylamidase, esterase and esterase lipase. We found, no activity of b-glucuronidase. Isolates from women with vaginitis had a high resistance to the tested antimycotics and a higher hydrolytic activity.

Keywords: Candida albicans, API ZYM, antimycogram

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750